By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Over 12 months, PROCEPT BioRobotics Corp saw more buying than selling from its insiders — purchases of about $11 million against sales of $624,000.
Desai Antal Rohit (Director) made the biggest buy, worth around $3.6 million. That includes C-suite money, which tends to get the most attention.
254 investment managers listed PRCT in their latest 13F filings (Q2 2026); more funds bought than sold. Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 3 of the last 7 full quarters.
Are insiders buying or selling PRCT stock?
In the last 12 months PROCEPT BioRobotics Corp insiders made open-market purchases worth about $11 million and sales worth about $624,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in PRCT?
The most recent open-market insider trade in PRCT was filed on 2026-09-10.
How many institutions own PRCT?
254 investment managers reported holding PRCT in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded PRCT?
No congressional trades in PRCT were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).